KAT I Antibodies

Santa Cruz Biotechnology provides a broad selection of KAT I Antibodies for investigating lysine acetyltransferase 1 (KAT I) in various biological processes. KAT I Antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KAT I plays a crucial role in regulating gene expression and protein function through the acetylation of lysine residues on histones and non-histone proteins. This modification is essential for various cellular processes, including cell cycle progression, differentiation, and response to stress. Understanding KAT I function is vital for elucidating its involvement in diseases such as cancer and neurodegenerative disorders. Researchers worldwide rely on monoclonal KAT I antibodies to advance their studies in protein acetylation mechanisms. Investigating KAT I activity provides valuable insights into cellular regulation and disease pathways. Current research utilizing KAT I monoclonal antibodies continues to reveal new aspects of lysine acetylation biology. Santa Cruz Biotechnology monoclonal KAT I antibodies enable researchers to make meaningful contributions to scientific understanding of acetylation processes and disease mechanisms.